| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000262380.1 |
Bosutinib |
Breast invasive carcinoma |
0.049110748 |
Resistant |
| ENSG00000262380.1 |
Bosutinib |
Kidney renal clear cell carcinoma |
0.016503352 |
Resistant |
| ENSG00000262380.1 |
Bosutinib |
Lung squamous cell carcinoma |
0.00137208 |
Resistant |
